Upcoming Conferences and Events
SBD/9/Sponsorships Advertising Marketing
BREATHE RIGHT CRUISES THROUGH FDA APPROVAL TO ADVERTISE
Published November 9, 1995
The FDA said Wednesday that CNS Inc. can advertise Breathe Right to chronic snorers, following an announcement Monday the company's patent application should be approved "within weeks," according to USA TODAY. Although CNS received FDA approval to sell the strips in '93, the company has been forbidden to advertise them. Del Jones of USA TODAY notes "most people know of" the product from watching football. CNS revenue grew from $2.8M in '94 to $36.5M in the first nine months of this year, but CEO Dan Cohen says the product "isn't a fad." He points out that only 10% of the strips are sold to athletes (USA TODAY, 11/9).